APAC healthcare hits ‘terrifying’ supply-demand inflexion point

Over half of patients surveyed feel they must see multiple doctors just for one diagnosis.

The Asia-Pacific healthcare sector has reached a "terrifying" inflexion point, defined by an incredible amount of demand and an environment of severely constrained supply.

Speaking at the Healthcare Asia Summit held in Singapore on 25 March, Alex Boulton, partner at Bain & Company, shared a new study by the company that said the region is facing a massive structural vacuum. Whilst the number of people seeking a single point of care to manage their journey has surged to 95%, only 30% of patients currently have one.

With 70% of the market up for grabs, the race to secure a "trusted position is the defining strategic challenge for the 2026 healthcare landscape.

This shift is driven by a diffusion of care that has moved treatment from hospitals into clinics, homes, and phones. Whilst this offers the convenience patients becoming consumers" now expect, it has birthed a crisis of coordination.

"The diffusion has led to confusion, which has led to a level of complexity, as your care is now being managed by many different individual stakeholders," Boulton said.

Currently, 50% of patients feel they "need to see multiple different doctors to receive the right diagnosis or treatment plan," and 43% find their healthcare advice "is inconsistent between providers." This complexity, coupled with "medical inflation [that] is out of control," has created a "really troubling" experience for the modern consumer.

The commercial incentive to solve this friction is significant, as loyalty serves as the ultimate defensive moat.

"Promoters are two and a half times less likely to switch healthcare providers. Promoters are two times less likely to use services from other providers," Boulton said.

In an era of low health insurance penetration and high out-of-pocket spend, these promoters represent the highest customer lifetime value. However, capturing this loyalty requires "interconnected journeys that are seamlessly online, offline, in the hospital, [and] out of the hospital," backed by consistent data and medical records.

The identity of the "trusted partner" varies significantly by market. In Singapore and Australia, primary care has "dug in the nails," whereas in Indonesia and the Philippines, "insurers are rocketing up the trust quotient."

To maintain this momentum, Boulton argues that insurers must fundamentally shift their business model.

"Stop administering, start managing. Redesign your highest friction member interactions... move from passive reimbursement to active stewardship," Boulton said.

Conversely, providers must "completely reimagine care delivery" and partner more deeply with clinicians, 61% of whom are "concerned" and "upset" because they do not feel part of the decision-making process regarding how AI tools are being deployed.

The ultimate winners in this "land grab" will be the organisations that can "zero-base the healthcare delivery mechanism" to handle a surge in demand. As consumers take "a lot more ownership over prevention" and spend more of their disposable income on health, the market will belong to those who can bridge the gap between clinical quality and digital convenience.

"The people asking for a single point of care to manage their care across this complex system has gone up from about 70% to 95% across the region, which is really substantial," Boulton said, noting that success requires moving beyond transactional "clipping the ticket" to provide a single, trusted point of accountability.